Applied body-fluid analysis by wearable devices
- PMID: 39633192
- PMCID: PMC12007731
- DOI: 10.1038/s41586-024-08249-4
Applied body-fluid analysis by wearable devices
Abstract
Wearable sensors are a recent paradigm in healthcare, enabling continuous, decentralized, and non- or minimally invasive monitoring of health and disease. Continuous measurements yield information-rich time series of physiological data that are holistic and clinically meaningful. Although most wearable sensors were initially restricted to biophysical measurements, the next generation of wearable devices is now emerging that enable biochemical monitoring of both small and large molecules in a variety of body fluids, such as sweat, breath, saliva, tears and interstitial fluid. Rapidly evolving data analysis and decision-making technologies through artificial intelligence has accelerated the application of wearables around the world. Although recent pilot trials have demonstrated the clinical applicability of these wearable devices, their widespread adoption will require large-scale validation across various conditions, ethical consideration and sociocultural acceptance. Successful translation of wearable devices from laboratory prototypes into clinical tools will further require a comprehensive transitional environment involving all stakeholders. The wearable device platforms must gain acceptance among different user groups, add clinical value for various medical indications, be eligible for reimbursements and contribute to public health initiatives. In this Perspective, we review state-of-the-art wearable devices for body-fluid analysis and their translation into clinical applications, and provide insight into their clinical purpose.
© 2024. Springer Nature Limited.
Conflict of interest statement
Competing interests: R.G. is co-founder and CEO of Epicore Biosystems. J.W. is founder and chief scientific officer at Persperion. W.G. is co-founder and advisor at Persperity Health. E.V. serves in the ethics advisory panel of Merck AG and in the ethics advisory panel of IQVIA. J.A.R. is a co-founder and advisor to Sibel Health, Sonica and Epicore Biosystems, and holds patents associated with these companies. The other authors declare no competing interests.
References
-
- Rizas KD et al. Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial. Nat. Med 28, 1823–1830 (2022). - PubMed
-
-
Kim J, Campbell AS, de Ávila BE & Wang J Wearable biosensors for healthcare monitoring. Nat. Biotechnol 37, 389–406 (2019).
This paper has been one of the most successful papers providing a differentiated outlook on the use of wearable devices including their clinical application.
-
-
- Ates HC & Dincer C Wearable breath analysis. Nat. Rev. Bioeng 1, 80–82 (2023).
-
-
Ates HC et al. End-to-end design of wearable sensors. Nat. Rev. Mater 7, 887–907 (2022).
This paper provides a differentiated overview on the modularity of wearable sensors and their potential to serve various and heterogeneous needs.
-
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources